{"name":"AskBio Inc","slug":"askbio-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"AB-1002","genericName":"AB-1002","slug":"ab-1002","indication":"Treatment of Duchenne muscular dystrophy","status":"phase_2"},{"name":"ACTUS-101","genericName":"ACTUS-101","slug":"actus-101","indication":"Other","status":"phase_1"},{"name":"AB-1005","genericName":"AB-1005","slug":"ab-1005","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"AB-1002","genericName":"AB-1002","slug":"ab-1002","phase":"phase_2","mechanism":"AB-1002 is a gene therapy that aims to treat certain genetic disorders by delivering a healthy copy of the gene.","indications":["Treatment of Duchenne muscular dystrophy"],"catalyst":""},{"name":"ACTUS-101","genericName":"ACTUS-101","slug":"actus-101","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"AB-1005","genericName":"AB-1005","slug":"ab-1005","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQYlZNamRfc1k2VzBoRzFzQjRqNC10OWxXMUdCTFhsbVl5ckdxbnpuelpHYWwzZTVFaEhVRlVpaEhFYXJ6Rzd3TFdDT0NzSkI5M0dLNGpWSnJIcjRnSGt5OWhhRjFtbWRtTC1PLTMxRGJqck5YODQ4ZlY1WmVfOVpzLUREMmpvVHpYek50QUIySm5oRWR0R2FzZkZBRFhwQQ?oc=5","date":"2026-04-02","type":"trial","source":"finance.yahoo.com","summary":"Bayer Advances AB-1002 Study, Highlights Pharma Growth Strategy - finance.yahoo.com","headline":"Bayer Advances AB-1002 Study, Highlights Pharma Growth Strategy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE5wRUd3WGx2NFdPMXlobnBFWHc2ZmVIelBuaEtacWJ2MkV3dGZ6d0tVaXZaLVd1c1pIclV5UnNYUUQtQjMyQjgwV1FvYXgyOWNYNklRX04yUUJUc1pmaEHSAWNBVV95cUxPWFVTY3I1a0FoRU95S2JzVVMyejV1Wm5lVnduUC1ZcFhpQTVwWDlKbi05bEhEazNJZlBpM081LUJFMFhOaDdIbjV6S0RoMjgzRFFpRmpGbjhoaUROakpSOVNpSGs?oc=5","date":"2026-04-02","type":"pipeline","source":"Bitget","summary":"Bayer Moves Forward with AB-1002 Research, Showcases Pharmaceutical Expansion Plan - Bitget","headline":"Bayer Moves Forward with AB-1002 Research, Showcases Pharmaceutical Expansion Plan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE9CeklIX3d2dzYyekdXYjJHV0VhNmNXQldST1k2TEU5T2ZIMEJKZDdPdV9FVnJvdUJsekdTcjd1cTlCUFViQjRSODgtbVRTSVU1bjhFcjNDby1xMlllN2NDd3REWEdIYmFkWTJURWRxSnd4QdIBckFVX3lxTFB4eXNSeXk2cUJsNzJ0QTJMdjJaUzluRmxlbU5lZy04LWhRYXJHMDNOUktfR2w2MzZwQ0FLc2QyYzMyVzNsQ2VqVWd4cDdEeWFjdGZQaWhqU3A1Y0NZczJqT0pfdGJMRkdkNE9aYnRpM2pnQQ?oc=5","date":"2026-01-12","type":"pipeline","source":"Raleigh News & Observer","summary":"RTP’s AskBio wants to make $4 billion price tag look like a bargain - Raleigh News & Observer","headline":"RTP’s AskBio wants to make $4 billion price tag look like a bargain - Raleigh News & Observer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPMHR4TWk2Q0RuTDh3eXk0OWh6c01XbVBxNzBhMGJpeERvN1Zkdm0zSzYtWmNLaDc5SDRZakxwODF3b2VTZERJSW1CSmk1OUJneVF1NVFMcXpueFZFckpncHlPWndmZnV2YjJhbE03V3dGREFCNW9SdHZBeHVxeWVjTlBR?oc=5","date":"2024-09-26","type":"deal","source":"Pharmaceutical Technology","summary":"AskBio and Belief BioMed partner to advance gene therapies - Pharmaceutical Technology","headline":"AskBio and Belief BioMed partner to advance gene therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQVG15QXBGNUNXemN6TDNWc2xXVDNOcmxsX3loMnd5R3VtWWdvcm5iUWR0SlQ2SG9uNG5xb0lJd1VRT0dtVGR4ejRzZngxVE9xd1JSeUNtbkZvT2dlYXNsN0IzVVFBdlJ5YjlMMGlRSEhTS19ldXc0WGhlRXZjeTRpQnZSSWlCenZabHhnMnBiQmsySVhXUkdpWkVKdjdDV2RxZnpvdWtJVWZfbmt1OTVXa2FWYjBkVjB3dERoejBzOA?oc=5","date":"2024-09-25","type":"pipeline","source":"Bayer","summary":"AskBio to collaborate with Belief BioMed to explore the potential of new gene therapies - Bayer","headline":"AskBio to collaborate with Belief BioMed to explore the potential of new gene therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPZ0dyNFQ5dy1qbmRnZmtDQ2o3WGtxRjNQVG1nczBkcE5CSWZJN2toUHJ4YUlkZkhIMGdSY0Vxb1BlS2dMa29OU3dEd2lkUGFPODQwODNGOHQ1LU94WnFBeW9LeHl3dXlkZlE2dTB4cm9IUU1lUnItcEhwX3VVNEJQUEhreDlRVXFWSTZLaFVMN2hjb2trcEE?oc=5","date":"2024-07-11","type":"pipeline","source":"The Pharma Letter","summary":"AskBio gains important designations for AB-1005 development - The Pharma Letter","headline":"AskBio gains important designations for AB-1005 development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxQZTl2LXcwMV8tTldLdmxybEtSQmtaZXBoQllnR3NKMjRpc1JLNHZFRDE3eDlwZzFOVGdLdkVKWkxQcGhjdTFQY3NLdDlXaEF6b0E0NzRpVUp2dkNhc2ZhZmN5TnR6bFZOTkNuMjltUE1zMnJtalFkaGgwdUpHMk1jZUpjR1RNY2REQUcxR2JBekdjYi0yQzVfUXdGalBuWkpWdWN3cHROZTJHaGNFUTAtT01DR2J4SERUMG1OWFFSS3NCclptMFZVYko0ZWk5SGRHTDA1VnNMMzJtbERCcHQ5b0ZSVncwS0NtT1dlUlNrNTZsU0JlSnFqOWJqaFA?oc=5","date":"2023-01-09","type":"deal","source":"PR Newswire","summary":"AskBio Announces Strategic Collaboration with ReCode Therapeutics to Explore Single Vector Gene Editing Platform - PR Newswire","headline":"AskBio Announces Strategic Collaboration with ReCode Therapeutics to Explore Single Vector Gene Editing Platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE5sbFQzR1JrMExpYllKRzBjbWNJN2JiTDdrOU4zV2RwbWE2ZmNPVTU4Q1MzWV9OWW9SaUxjSmJGY2VOTG83Y1F2TTdKTFZNazdOUU96Vk51QlJDbFRZWVNyUzExLUM3SGh5VWlIOVJsTDdRQzFybjdNdkdHaG0xdw?oc=5","date":"2021-02-02","type":"trial","source":"Cure Parkinson's","summary":"‘AskBio’ acquires BNB and GDNF gene therapy trials - Cure Parkinson's","headline":"‘AskBio’ acquires BNB and GDNF gene therapy trials - Cure Parkinson's","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQeHhDZW1WYlV4WGlhQ2ttV3RkNXVaM1hmQmpIU093Yk1UVHg4bXM3d1hweHV4dnZUNFlKaWhnbmNaWmhMREZxM1pDMk1yejRQRlhWT2hlemNNQktXVjhzdUwwTzBCMWFyNWRqSk5wQTVUTVhJS0NYSjhLSGtWVzhwVnllY28tdVc5SXUyVk5qV2VwcmcydjVkY0dkS0pKUGJE?oc=5","date":"2020-10-26","type":"deal","source":"tpg.com","summary":"Bayer Acquires Asklepios BioPharmaceutical to Broaden Innovation Base in Cell and Gene Therapy - tpg.com","headline":"Bayer Acquires Asklepios BioPharmaceutical to Broaden Innovation Base in Cell and Gene Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQbGRZeTFVUVpmNFB0MEpPRjBQMk1ua08zSVQzRlZ0Tm5Ud21nSkRoajQzb0VxbU4wQWNWcjMzeEFQbUZMR1BGV3U1UDVzR1V6UlBjVU53V1g1YjZRUlllbTZhQ2UzdTNfVm5Fa0Znem8ySnRISFJfQXFLVko0X0phYmNMa0lfMHNoc0JZVGtpSHdPMjNERmhZUjBpbHhuYlFvM3RENENhMXdMT0E?oc=5","date":"2020-10-26","type":"pipeline","source":"Bloomberg.com","summary":"Bayer to Spend Up to $4 Billion for AskBio’s Gene Therapies - Bloomberg.com","headline":"Bayer to Spend Up to $4 Billion for AskBio’s Gene Therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxORk15UzFDLUFEMGJxa0ozMmw1bWRWWnpXX3gxRldWZXRrTnNpMGQ1ZXYtWmdRa2p2ZEF5ZmduZXJwTk1qTnZoM3VDdkRjQi1UWUV4VFJaZkpoM2J5amY4NzhsQ1VjMV9ieWdwN0FfakpDd0NoWHd4cWRCTnhpT25RT1dpZzJMaks3aFlJ?oc=5","date":"2020-10-26","type":"deal","source":"BioPharma Dive","summary":"Bayer to buy AskBio for $2B in bid to become a gene therapy player - BioPharma Dive","headline":"Bayer to buy AskBio for $2B in bid to become a gene therapy player","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE1MeFZXb3kydUdoQWpqcVVSbExGdW9PUVpnWDRlaGRtdVA1QlBwNUJleEJfRWJrUTJpZFNtM01EdGdhUW0xM1ZwZVpSUlFQU3Awbzg3c0ZibUw3MEN4bUItaWZkNEkxcDY4UUVDYVljSFNlX3VVeGhETHllM2MyQQ?oc=5","date":"2020-04-22","type":"deal","source":"Contract Pharma","summary":"AskBio Acquires BrainVectis - Contract Pharma","headline":"AskBio Acquires BrainVectis","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_2":2,"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}